Natural History of Central Retinal Vein Occlusion: An Evidence-Based Systematic Review

视网膜中央静脉阻塞 医学 自然史 眼科 视力 青光眼 黄斑水肿 外科 内科学
作者
Rachel L. McIntosh,Sophie Rogers,Lyndell L. Lim,Ning Cheung,Jie Jin Wang,Paul L.R. Mitchell,Jonathan W. Kowalski,Hiep P. Nguyen,Tien Yin Wong
出处
期刊:Ophthalmology [Elsevier BV]
卷期号:117 (6): 1113-1123.e15 被引量:643
标识
DOI:10.1016/j.ophtha.2010.01.060
摘要

Objective

To describe the natural history of central retinal vein occlusion (CRVO) based on the best available evidence from the literature.

Clinical Relevance

Central retinal vein occlusion is a common sight-threatening retinal vascular disease. Despite the introduction of new interventions, the natural history of CRVO is unclear.

Methods

Systemic review of all English language articles retrieved using a keyword search of MEDLINE, EMBASE, Current Contents, and the Cochrane Library to November 13, 2008. This was supplemented by hand-searching references of review articles published within the last 5 years. Two investigators independently identified all relevant observational studies evaluating the natural history of RVO and all clinical trials evaluating interventions for CRVO; an untreated control arm was included.

Results

Of 5966 citations retrieved, 53 studies were reviewed, providing 3271 eyes with CRVO for analysis of its natural history. Visual acuity (VA) was generally poor at baseline (<20/40) and decreased further over time. Although 6 studies reported an improvement in VA, none of these improvements resulted in VA better than 20/40. Up to 34% of eyes with nonischemic CRVO converted to ischemic CRVO over a 3-year period. In ischemic CRVO cases, neovascular glaucoma developed in at least 23% of eyes within 15 months. In nonischemic CRVO cases, macular edema resolved in approximately 30% of eyes over time, and subsequent neovascular glaucoma was rare.

Conclusions

Untreated eyes with CRVO generally had poor VA, which declined further over time. One quarter of eyes with nonischemic CRVO converted to ischemic CRVO.

Financial Disclosure(s)

Proprietary or commercial disclosure may be found after the references.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
qaplay发布了新的文献求助10
刚刚
duojiala完成签到,获得积分10
刚刚
领导范儿的应助被什玖采纳,获得10
1秒前
超级无敌的应助被方俊驰采纳,获得10
1秒前
shine发布了新的文献求助10
1秒前
大模型的应助被会飞的鱼采纳,获得10
2秒前
满意夜山发布了新的文献求助10
2秒前
佛光辉发布了新的文献求助10
3秒前
svt177188发布了新的文献求助10
3秒前
王大壮完成签到,获得积分0
4秒前
DIAPTERA完成签到,获得积分10
5秒前
科研通AI2S的应助被jolinchristina采纳,获得10
5秒前
姚友进发布了新的文献求助10
7秒前
Hao完成签到 ,获得积分10
8秒前
9秒前
9秒前
9秒前
苒苒发布了新的文献求助10
10秒前
10秒前
10秒前
hehe完成签到,获得积分10
11秒前
乐乐的应助被terryok采纳,获得50
11秒前
11秒前
水煮电吹风的应助被方俊驰采纳,获得10
12秒前
碎月发布了新的文献求助10
13秒前
13秒前
13秒前
13秒前
13秒前
14秒前
什玖发布了新的文献求助10
14秒前
会飞的鱼发布了新的文献求助10
14秒前
dd发布了新的文献求助10
15秒前
渡花发布了新的文献求助10
15秒前
英俊的迎梦完成签到 ,获得积分10
15秒前
15秒前
16秒前
child完成签到 ,获得积分10
16秒前
细腻芹菜发布了新的文献求助50
16秒前
FashionBoy的应助被Twinkle采纳,获得10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189382
求助须知:如何正确求助?哪些是违规求助? 9576691
关于积分的说明 21849410
捐赠科研通 7787318
什么是DOI,文献DOI怎么找? 3435538
关于科研通互助平台的介绍 2559748
邀请新用户注册赠送积分活动 2482509